awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q44001619-35934624-3938-4076-B6A3-740782FFB984
Q44001619-35934624-3938-4076-B6A3-740782FFB984
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44001619-35934624-3938-4076-B6A3-740782FFB984
Treatment options for rheumatoid arthritis beyond TNF-α inhibitors.
P2860
Q44001619-35934624-3938-4076-B6A3-740782FFB984
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44001619-35934624-3938-4076-B6A3-740782FFB984
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
11e7d916e4e21edea871a8a123fcc1220a8015fd
P2860
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.